An observational study in Central Sensitisation, Fibromyalgia and Neck Pain, sponsored by University Ghent. Recruiting at 1 site in Belgium. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-01-05.
Sponsored by University Ghent · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 23 studies in Fibromyalgia with a site in Belgium — 7 open to participants now, 7 under way, none of them phase 3. Fibromyalgia · Belgium.
Among the 23 studies in Fibromyalgia with a site in Belgium, this one is one of 3 that started in 2022, is one of 9 observational ones, and was the 15th registered.
1,245 studies on the registry are indexed under Fibromyalgia; 256 are open to participants now.
Browse Fibromyalgia studies →7 of the 23 studies in Fibromyalgia with a site in Belgium are open now. Recruiting first, the newest first:
Vrije Universiteit Brussel · Sites in Belgium
Ages 18–70 · Healthy volunteers
Universitair Ziekenhuis Brussel · Sites in Belgium
Ages 18+
Vrije Universiteit Brussel · Sites in Belgium
Ages 18+ · Healthy volunteers
Hasselt University · Sites in Belgium
Ages 18–65
Hasselt University · Sites in Belgium
Ages 18–65 · Healthy volunteers
A study can be open while its sites in Belgium have not opened yet or have stopped. Only those recruiting at a site in Belgium →
Of the 161 Fibromyalgia studies recruiting now, 51 (32%) set no upper age limit and 96 (60%) stop at 75 or younger; 15 take children under 18; 35 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
23 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 3 · Phase 2 3 · Phase 3 2
First in 2004; this study’s year is marked. 3 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 240 is above the median of 100 across 280 observational studies indexed under Fibromyalgia.
Median enrollment 60 across the 13 interventional studies, 100 across the 9 observational. Of the 10 that completed or were terminated, 1 (10%) have results posted.
This tab as a report to print or save as PDF → With an account.
5 of 23 have an industry lead sponsor. The 10 most frequent:
University Ghent is the lead sponsor of 350 studies on the registry; 86 are open to participants now.
University Ghent has 4 studies filed under Fibromyalgia — fewer than ten, so there is no comparison to draw.
2 of the studies in Fibromyalgia with a site in Belgium that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06892977University GhentMapping Stress and Pain Interactions (G072323N) | 2026-12 |
| NCT07176078Universitair Ziekenhuis BrusselEvaluating the Added Benefit of Osteopathic Care to a Flexi-FODMAP Diet in Fibromyalgia Patients With Irritable Bowel Syndrome | 2026-12 |
Add all 2 to your calendar (.ics) → With an account.
Among the 23 studies in Fibromyalgia with a site in Belgium, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This experimental study will investigate whether the decreased NFR threshold and increased NFR temporal summation, which are frequently observed in chronic pain patients, are only symptomatic manifestations that occur in the involved limb and indicate peripheral sensitization or generalized manifestations that are also present in the non-involved limbs and thus indicate central sensitization. To gain an idea of the presence of central sensitization, this study will also investigate whether there are increased perception and decreased pain thresholds in response to electrical, thermal, and mechanical stimulation, as well as whether there is a decreased conditioned pain modulation. To investigate this, it is essential to examine different pain populations and locations, in particular, acute pain versus chronic pain populations to compare peripheral versus central sensitization, respectively. Recently, our research group has shown that patients with a traumatic origin of chronic neck pain (chronic whiplash-associated disorders) show central sensitization in contrast to patients with a non-traumatic origin (chronic idiopathic neck pain) who demonstrate only indications for peripheral sensitization. Therefore, this study will also distinguish between complaints of traumatic and non-traumatic origin.
The measurements will be performed at different locations, namely the lower and upper limbs. To determine whether the differences depend on the measurement location (= location where experimental nociceptive stimulation is administered) and symptom location (= location of clinical nociceptive stimulation), different patient populations will be compared with each other, as well as with a healthy control population. In acute and chronic whiplash patients and patients with acute and chronic idiopathic neck pain complaints, the complaints are primarily localized in the upper limb. It is hypothesized that in chronic neck pain patients (both whiplash and idiopathic neck pain patients) abnormal values are found in both the upper and lower limbs compared to the healthy controls due to central sensitization. In acute neck pain patients (both whiplash and idiopathic neck pain) only abnormal values in the arm are expected and not in the leg as a result of peripheral sensitization. It is hypothesized that patients with neck pain of traumatic origin will show a stronger sensitization than those with neck pain of non-traumatic origin. In acute and chronic low back pain patients, the complaints are primarily localized in the lower body quadrant. As a result of central sensitization in the chronic low back pain patients, abnormal values are expected in both the upper and lower limbs, while only abnormal values in the leg are expected as a result of peripheral sensitization in the acute low back pain patients. Finally, this study will investigate whether chronic low back and neck pain patients show a similar pattern of central sensitization as fibromyalgia patients, a population with generalized complaints that are primarily attributed to central sensitization.
Inclusion Criteria Fibromyalgia patients:
Inclusion Criteria neck pain patients:
Inclusion Criteria low back pain patients:
Inclusion Criteria healthy controls:
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Fibromyalgia patients diagnosed according to the 2010 ACR-criteria
* Patients with non-specific, idiopathic neck pain complaints * Patients with neck pain complaints of traumatic origin type whiplash grade 1 (pain, stiffness or tenderness of the neck and no objective physical abnormalities) and grade 2 (neck complaints and musculoskeletal disorders such as reduced range of motion and tender pain points) according to the Quebec Task Force on Whiplash Associated Disorders
Patients with non-specific, idiopathic back pain complaints
Age, sex and BMI-matched healthy controls
Quantitative sensory testing (QST) - electrical detection threshold
Determination of sensory detection thresholds in response to electrical stimuli which are delivered transcutaneously over the n. suralis and n. medianus, recorded in mA.
Time frame: Baseline
Quantitative sensory testing (QST) - electrical pain threshold
Determination of sensory pain threshold in response to electrical stimuli which are delivered transcutaneously over the n. suralis and n. medianus, recorded in mA.
Time frame: Baseline
Quantitative sensory testing (QST) - thermal detection threshold
Determination of sensory detection thresholds in response to thermal stimuli which are delivered to the skin using a thermode, recorded in °C: * cold detection threshold * warmth detection threshold
Time frame: Baseline
Quantitative sensory testing (QST) - thermal pain threshold
Determination of sensory pain thresholds in response to thermal stimuli which are delivered to the skin using a thermode, recorded in °C: * cold pain threshold * heat pain threshold
Time frame: Baseline
Quantitative sensory testing (QST) - discrimination between thermal stimuli
Determination of the number of paradoxical heat sensations in response to alternating cold and warm stimuli delivered to the skin using a thermode.
Time frame: Baseline
Quantitative sensory testing (QST) - tactile detection threshold
Determination of tactile detection threshold, assessed using Von Frey monofilaments, recorded in mN
Time frame: Baseline
Quantitative sensory testing (QST) - mechanical pain threshold
Determination of mechanical pain threshold, assessed using pinprick stimulators, recorded in mN
Time frame: Baseline
Quantitative sensory testing (QST) - sensitivity to pressure stimuli
Determination of pressure pain threshold, assessed using pressure algometry, recorded in kg
Time frame: Baseline
Quantitative sensory testing (QST) - temporal summation of electrical stimuli
Determination of temporal summation in response to electrical stimuli delivered transcutaneously over the skin of the n. suralis and n. medianus. The numerical pain rating in response to these stimuli (range 0 - 100) will be recorded.
Time frame: Baseline
Quantitative sensory testing (QST) - spinal hyperexcitability
Determination of spinal hyperexcitability using the nociceptive flexion reflex (NFR; sensitization of spinal cord neurons), recorded in mA
Time frame: Baseline
Quantitative sensory testing (QST) - temporal summation of spinal hyperexcitability
Determination of temporal summation of the nociceptive flexion reflex (NFR; sensitization of spinal cord neurons), recorded using a numeric pain rating scale (range 0 - 100)
Time frame: Baseline
Quantitative sensory testing - conditioned pain modulation
Determination of condition pain modulation (aka. pain inhibits pain) by means of a heterotopic noxious counterstimulation paradigm. Test stimuli comprise of pressure pain threshold assessments and application of a heat stimulus (using a thermode) corresponding to a temperature eliciting a visual analog scale rating of 5/10. Test stimuli will be applied before, during and after the conditioning stimulus which is the immersion of the hand in a hot circulating water bath of 45.5°C.
Time frame: Baseline
Central sensitization inventory
Self-report measure of signs and symptoms associated with central sensitization
Time frame: Baseline
Douleur Neuropathique 4 Questionnaire
Clinician administered questionnaire for evaluation of signs and symptoms associated with neuropathic pain
Time frame: Baseline
Pain catastrophizing scale
Self-report measure of pain perceptions and cognitions
Time frame: Baseline
Pain vigilance and awareness questionnaire
Self-report measure assessing preoccupation with and attention to pain
Time frame: Baseline
Tampa scale for kinesiophobia
Self-report measure assessing fear of movement
Time frame: Baseline
International physical activity questionnaire
Self-report measure of physical activity in preceeding 7 days
Time frame: Baseline
Patient-reported outcomes measurement information system - physical functioning
Self-report measure of health-related domains relating to physical functioning
Time frame: Baseline
Patient-reported outcomes measurement information system - anxiety
Self-report measure of health-related domains relating to anxiety
Time frame: Baseline
Patient-reported outcomes measurement information system - depression
Self-report measure of health-related domains relating to depression
Time frame: Baseline
Patient-reported outcomes measurement information system - fatigue
Self-report measure of health-related domains relating to fatigue and sleep disruption
Time frame: Baseline
Patient-reported outcomes measurement information system - participation
Self-report measure of health-related domains relating to participation in social activities
Time frame: Baseline
Patient-reported outcomes measurement information system - pain interference
Self-report measure of health-related domains relating to pain interference
Time frame: Baseline
Injustice Experience Questionnaire
Self-report measure of perceived injustice
Time frame: Baseline
Pain Disability Index
Self-report measure of pain-related disability
Time frame: Baseline
Plan to share: Undecided
No publications or documents are linked to this record.
Started Apr 2022 (actual). Primary completion is estimated for Oct 2024, 30 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.